Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-24

Clinical Trial Update: Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer. [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating abemaciclib in combination with endocrine therapy for older patients with breast cancer is currently recruiting. The study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VERZENIO (ABEMACICLIB)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Anatomic Stage IV Breast Cancer AJCC v8, Hormone Receptor Positive Breast Carcinoma | Phase 2 | Status: RECRUITING